EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Pulmonary Embolism in Hospitalized COVID-19 Patients: Incidence, Clinical Predictors, and Short-Term Outcomes

Cristiana Adina Avram iD, Maria-Laura Craciun, Ana-Maria Pah, Stela Iurciuc iD, Simina Crisan iD, Cristina Vacarescu, Ioana Cotet, Claudia Raluca Balasa Virzob iD, Dan Alexandru Surducan, Claudiu Avram

Journal of Clinical Medicine · 19.04.2026 · 15 (8) · 3117

DOI: 10.3390/jcm15083117 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 19.04.2026. Verfasst von Cristiana Adina Avram und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine I, "Victor Babes" University of Medicine and Pharmacy Timisoara, Eftimie Murgu Square 2, 300041 Timisoara, Romania. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Victor Babeș University of Medicine and Pharmacy Timișoara, Victor Babeș University of Medicine and Pharmacy, Timișoara, Romania.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Pulmonary embolism (PE) represents a major thrombotic complication in hospitalized patients with coronavirus disease 2019 (COVID-19), yet data on its incidence, clinical predictors, and short-term outcomes in actual cohorts remain heterogeneous.

Methods

We conducted a retrospective observational cohort study including 395 consecutive adults hospitalized with RT-PCR-confirmed COVID-19 at a tertiary infectious diseases center between March 2020 and December 2024. Clinical, laboratory, imaging, and treatment data were extracted from electronic records, and PE was defined by computed tomography pulmonary angiography. Univariable and multivariable logistic regression analyses were used to identify independent predictors of PE in the subset of patients who underwent CTPA (n = 120), in whom PE status was definitively ascertained (47 with PE and 73 without PE).

Results

Pulmonary embolism was diagnosed in 47 patients (11.9%). Patients with PE more frequently had prior venous thromboembolism (19.1% vs. 8.3%) and prolonged immobilization (61.7% vs. 23.0%), and were more often admitted to the intensive care unit (12.8% vs. 4.3%) than those without PE. Peak D-dimer levels were almost ten-fold higher in the PE group (median 5322 vs. 529.5 µg/L). In multivariable logistic regression, peak D-dimer was independently associated with PE (per log-unit increase, adjusted OR 3.9, 95% CI 2.1–7.1), and prolonged immobilization conferred a substantially higher risk of PE (adjusted OR 5.1, 95% CI 2.4–10.9). Patients with PE experienced more complex hospital courses and more frequent need for advanced therapies, although in-hospital mortality did not differ significantly between groups.

Conclusions

In hospitalized COVID-19 patients, PE is frequent and closely linked to marked D-dimer elevation and acquired in-hospital risk factors, particularly prolonged immobilization. This evidence supports the use of dynamic D-dimer assessment and careful evaluation of immobilization status to improve risk stratification, guide decisions on diagnostic imaging and anticoagulation intensity, and identify patients who may benefit from closer post-discharge cardiovascular follow-up (this hypothesis requires confirmation in future prospective studies).

Schlagwörter

Stichwörter der Autor:innen

COVID-19D-dimeranticoagulationimmobilizationlong COVIDpulmonary embolismrisk stratificationvenous thromboembolism

Autor:innen und Institutionen

  • Department of Internal Medicine I, "Victor Babes" University of Medicine and Pharmacy Timisoara, Eftimie Murgu Square 2, 300041 Timisoara, Romania.
  • Cardiology Department, "Victor Babes" University of Medicine and Pharmacy Timisoara, Eftimie Murgu Square 2, 300041 Timisoara, Romania.
  • Department of General Medicine, Doctoral School, "Victor Babes" University of Medicine and Pharmacy Timisoara, Eftimie Murgu Square 2, 300041 Timisoara, Romania.
  • Department of Clinic Nursing, "Victor Babes" University of Medicine and Pharmacy Timisoara, Eftimie Murgu Square 2, 300041 Timisoara, Romania.
  • Department of Functional Sciences, Discipline of Public Health, Center for Translational Research and Systems Medicine, "Victor Babes" University of Medicine and Pharmacy Timisoara, Eftimie Murgu Square 2, 300041 Timiso…
  • Centre for Translational Research and Systems Medicine, Faculty of Medicine, "Victor Babes" University of Medicine and Pharmacy Timisoara, Eftimie Murgu Square 2, 300041 Timisoara, Romania.

ORCID-Profile: Cristiana Adina Avram, Stela Iurciuc, Simina Crisan, Claudia Raluca Balasa Virzob

Förderung

  • Victor Babeș University of Medicine and Pharmacy Timișoara
  • Victor Babeș University of Medicine and Pharmacy, Timișoara, Romania

Zitieren

APA

Avram, C. A., Craciun, M. L., Pah, A. M., Iurciuc, S., Crisan, S., Vacarescu, C., Cotet, I., Virzob, C. R. B., Surducan, D. A., & Avram, C. (2026). Pulmonary Embolism in Hospitalized COVID-19 Patients: Incidence, Clinical Predictors, and Short-Term Outcomes. Journal of Clinical Medicine, 15(8), 3117. https://doi.org/10.3390/jcm15083117

Vancouver

Avram CA, Craciun ML, Pah AM, Iurciuc S, Crisan S, Vacarescu C, et al. Pulmonary Embolism in Hospitalized COVID-19 Patients: Incidence, Clinical Predictors, and Short-Term Outcomes. Journal of Clinical Medicine. 2026;15(8):3117. doi:10.3390/jcm15083117

BibTeX
@article{Avram2026,
  author = {Avram, Cristiana Adina and Craciun, Maria-Laura and Pah, Ana-Maria and Iurciuc, Stela and Crisan, Simina and Vacarescu, Cristina and Cotet, Ioana and Virzob, Claudia Raluca Balasa and Surducan, Dan Alexandru and Avram, Claudiu},
  title = {Pulmonary Embolism in Hospitalized COVID-19 Patients: Incidence, Clinical Predictors, and Short-Term Outcomes},
  journal = {Journal of Clinical Medicine},
  year = {2026},
  volume = {15},
  number = {8},
  pages = {3117},
  doi = {10.3390/jcm15083117}
}
Kostenlos starten →